✦ LIBER ✦

More on survival consumption costs in cost-utility analysis

✍ Scribed by John A. Nyman

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 76 KB
Volume: 15
Category: Article
ISSN: 1057-9230
DOI: 10.1002/hec.1067

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should the consumption of survivors be i

Should the consumption of survivors be included as a cost in cost–utility analysis?

✍ John A. Nyman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Abstract Survivor costs are those costs associated with a treatment because it extends the patient's life. A controversy exists regarding whether survivor consumption costs should be included in cost–utility analyses. The present paper uses this controversy to motivate a general reexamination of

On survival consumption costs – a reply

On survival consumption costs – a reply to Nyman

✍ Douglas Lundin; Joakim Ramsberg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

The issue of survival consumption costs in cost-utility analysis (CUA) has been debated several times, e.g. when the Washington Panel issued their report (Gold et al., 1996) and when Meltzer (1997) published his article. But as Richardson (1990) has described, already in the 1960s there was some dis

On the survival assumption in marginal (

On the survival assumption in marginal (cost) pricing

✍ Kazuya Kamiya 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 640 KB

Cost-utility analysis of treatment strat

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis

✍ Van den Hout, Wilbert B. ;Goekoop-Ruiterman, Yvonne P. M. ;Allaart, Cornelia F. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

Is there a case for using visual analogu

Is there a case for using visual analogue scale valuations in cost-utility analysis?

✍ David Parkin; Nancy Devlin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract This paper critically reviews theoretical and empirical propositions regarding visual analogue scale (VAS) valuations of health states and their use in cost‐utility analysis (CUA). A widely repeated assertion in the economic evaluation literature is the inferiority, on theoretical groun

Survival and cost-effectiveness analysis

Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma

✍ Willscott E. Naugler; Amnon Sonnenberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

The aim of the present study is to compare the survival rates and cost-effectiveness of different treatment strategies for small (<2 cm) hepatocellular carcinoma (HCC). Markov chains are developed to model different management strategies for patients with compensated cirrhosis and small HCC. Probabi